TCL Archive IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators May 21, 1993
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network. July 7, 2006
TCL Archive Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal January 25, 2013